CAS: 2178049-58-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ACT-1004-1239 REF: TM-T39665CAS: 2178049-58-4 | 98.31% | 219,00 €~2.804,00 € | Mar 29 Abr 25 |
 | ACT 1004-1239 REF: 3D-FA181705CAS: 2178049-58-4 | Min. 95% | - - - | Producto descatalogado |
ACT-1004-1239
CAS:2178049-58-4
ACT-1004-1239 is a CXCR7 antagonist with immunomodulatory and myelination-promoting effects, used for research on inflammatory …
Fórmula:
C27H28F2N6O3
Pureza:
98.31%
Forma y color:
Liquid
Peso molecular:
522.55
Ref: TM-T39665
| 1mg | 219,00 € | ||
| 5mg | 545,00 € | ||
| 10mg | 879,00 € | ||
| 25mg | 1.745,00 € | ||
| 50mg | 2.804,00 € |
Entrega estimada en Estados Unidos, el Martes 29 de Abril de 2025
ACT 1004-1239
CAS:2178049-58-4
Please enquire for more information about ACT 1004-1239 including the price, delivery time and more …
Fórmula:
C27H28F2N6O3
Pureza:
Min. 95%
Peso molecular:
522.55 g/mol
Ref: 3D-FA181705
| Tamaño no definido | Descatalogado | Solicitar información |
